Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice

Clicks: 393
ID: 270849
2007
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #25 of 105 articles by views in Antimicrobial agents and chemotherapy

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
T-705 (6-fluoro-3-hydroxy-2-pyrazinecarboxamide) was inhibitory to four strains of avian H5N1 influenza virus in MDCK cells, with the 90% effective concentrations ranging from 1.3 to 7.7 microM, as determined by a virus yield reduction assay. The efficacy was less than that exerted by oseltamivir ca …
Reference Key
rw2007antimicrobialefficacy Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sidwell RW;Barnard DL;Day CW;Smee DF;Bailey KW;Wong MH;Morrey JD;Furuta Y;;
Journal Antimicrobial agents and chemotherapy
Year 2007
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/17194832
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE Mice animals humans pubmed abstract nih national institutes of health national library of medicine research support N.I.H. Extramural Comparative Study Cells Cultured Inbred BALB C Viral Survival Analysis lung / pathology antiviral agents / administration & dosage antiviral agents / therapeutic use* influenza human / drug therapy* cytopathogenic effect virus replication / drug effects oxygen / blood influenza a virus lung / virology human / virology oseltamivir / therapeutic use human / pathology pmid:17194832 pmc1803113 doi:10.1128/aac.01051-06 robert w sidwell dale l barnard yousuke furuta amides / administration & dosage amides / therapeutic use* h5n1 subtype* pyrazines / administration & dosage pyrazines / therapeutic use*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.